Skip to main content

Table 8 Price ratios by medicine source and category for all medicine products and by therapeutic category, (median (interquartile range)), 2010–2014

From: How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014

WHO ATC level 1 categoryLocal genericsImported genericsOriginator
All products1.45 (0.94–2.57)2.14 (1.07–4.34)4.04 (1.50–6.88)
A – Alimentary tract and metabolism1.44 (1.18–2.57)2.09 (1.24–4.71)1.52 (0.97–4.39)
B – Blood and blood forming organs1.95 (1.59–16.78)4.89 (2.80–8.19)3.20 (2.25–3.27)
C – Cardiovascular system1.42 (0.81–2.09)3.09 (1.00–4.37)7.43 (4.60–14.59)
D – Dermatalogicals1.00 (0.44–1.50)1.46 (1.12–1.70)1.08 (0.36–1.80)
G – Genito-urinary system and sex hormones0.42 (0.39–0.52)1.16 (0.56–2.84)4.59 (3.12–6.43)
H - Systemic hormonal preparations, excluding sex hormones and insulins1.70 (1.06–2.13)0.82 (0.58–1.33)0.52 (0.23–0.91)
J – Anti-infectives for systemic use1.80 (1.24–4.33)2.74 (1.60–5.00)4.45 (1.92–7.79)
L – Antineoplastic agents and immunomodulating agents1.28 (0.46–2.55)1.73 (1.70–2.13)
M – Musculo-skeletal system1.11 (0.45–1.88)4.28 (2.72–6.77)5.13 (1.42–8.74)
N – Nervous system1.17 (0.66–2.69)2.24 (1.57–6.21)4.35 (1.03–5.19)
P – Antiparasitic products, insecticides and repellents1.79 (1.28–2.00)3.14
R – Respiratory system2.13 (0.62–3.57)1.75 (1.06–4.25)
S – Sensory organs1.13 (0.82–1.32)2.36 (1.42–3.46)0.65 (0.22–5.57)